Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wisinski

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Role of the androgen receptor in triple-negative breast cancerMurtuza Rampurwala, Kari B Wisinski, Ruth O'Regan
Clinical Practice and Cases in Emergency Medicine|November 23, 2021
The Tired Pregnant WomanKatie VanNatta, Nicole Yuzuk, David Trotter, et al.
Nursing Economic$|July 6, 2018
Video Monitoring to Reduce Falls And Patient Companion Costs For Adult InpatientsLisbeth Votruba, Bridget Graham, Jeana Wisinski, et al.
Clinical Breast Cancer|June 8, 2022
Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment StrategiesJohanna E Poterala, Thomas Havighurst, Kari Braun Wisinski
Clinical Advances in Hematology & Oncology : H&O|May 12, 2007
Panitumumab in metastatic colorectal cancerKari B Wisinski, Mary F Mulcahy, Al B Benson
JBJS Case Connector|March 17, 2023
Trapezoid Stress Fracture in an Olympic-Level Gymnast: A Case ReportNicholas M Bertha, Jeffrey J Wisinski, Kenneth F Taylor
Journal of Oncology Practice|November 19, 2016
Endocrine Therapy in Premenopausal Hormone Receptor-Positive Breast CancerAmye J Tevaarwerk, Kari B Wisinski, Ruth M O'Regan
The Lancet. Oncology|April 3, 2010
In the interest of full disclosureMark E Burkard, Amye J Tevaarwerk, Kari B Wisinski
The AAPS Journal|June 7, 2017
The EP3 Receptor/G<sub>z</sub> Signaling Axis as a Therapeutic Target for Diabetes and Cardiovascular DiseaseMichael D Schaid, Jaclyn A Wisinski, Michelle E Kimple
Clinical Breast Cancer|July 7, 2023
Is the Androgen Receptor a Viable Target in Triple Negative Breast Cancer in 5 Years?Marina N Sharifi, Ruth M O'Regan, Kari B Wisinski
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Role of the androgen receptor in triple-negative breast cancerMurtuza Rampurwala, Kari B Wisinski, Ruth O'Regan
Clinical Practice and Cases in Emergency Medicine|November 23, 2021
The Tired Pregnant WomanKatie VanNatta, Nicole Yuzuk, David Trotter, et al.
Nursing Economic$|July 6, 2018
Video Monitoring to Reduce Falls And Patient Companion Costs For Adult InpatientsLisbeth Votruba, Bridget Graham, Jeana Wisinski, et al.
Clinical Breast Cancer|June 8, 2022
Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment StrategiesJohanna E Poterala, Thomas Havighurst, Kari Braun Wisinski
Clinical Advances in Hematology & Oncology : H&O|May 12, 2007
Panitumumab in metastatic colorectal cancerKari B Wisinski, Mary F Mulcahy, Al B Benson
JBJS Case Connector|March 17, 2023
Trapezoid Stress Fracture in an Olympic-Level Gymnast: A Case ReportNicholas M Bertha, Jeffrey J Wisinski, Kenneth F Taylor
Journal of Oncology Practice|November 19, 2016
Endocrine Therapy in Premenopausal Hormone Receptor-Positive Breast CancerAmye J Tevaarwerk, Kari B Wisinski, Ruth M O'Regan
The Lancet. Oncology|April 3, 2010
In the interest of full disclosureMark E Burkard, Amye J Tevaarwerk, Kari B Wisinski
The AAPS Journal|June 7, 2017
The EP3 Receptor/G<sub>z</sub> Signaling Axis as a Therapeutic Target for Diabetes and Cardiovascular DiseaseMichael D Schaid, Jaclyn A Wisinski, Michelle E Kimple
Clinical Breast Cancer|July 7, 2023
Is the Androgen Receptor a Viable Target in Triple Negative Breast Cancer in 5 Years?Marina N Sharifi, Ruth M O'Regan, Kari B Wisinski
Pageof 14